| Dr Simon B Zeichner, DO | |
|
7305 N Military Trl, Riviera Beach, FL 33410-7417 | |
| (561) 422-8262 | |
| Not Available |
| Full Name | Dr Simon B Zeichner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 7305 N Military Trl, Riviera Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033467295 | NPI | - | NPPES |
| 1033467295 | Other | NPI | |
| 020539600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | OS11849 (Florida) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | OS11849 (Florida) | Primary |
| Entity Name | Baptist Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376779892 PECOS PAC ID: 9638215734 Enrollment ID: O20091002000436 |
News Archive
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Researchers examined the insurance claims and medical records of 681 patients with multiple sclerosis (MS) and found those who adhered to medication schedules had significantly better physical outcomes than patients who did not, although the total overall costs for their care were higher.
The effect of visit-to-visit blood pressure variability on mortality may be partly caused by changes in average values over time, say researchers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Simon B Zeichner, DO 7305 N Military Trl, Riviera Beach, FL 33410-7417 Ph: (561) 422-8262 | Dr Simon B Zeichner, DO 7305 N Military Trl, Riviera Beach, FL 33410-7417 Ph: (561) 422-8262 |
News Archive
A new study, released as a preprint on the bioRxiv* server, presents a new monoclonal antibody (MAb) called DZIF-10c that powerfully neutralizes SARS-CoV-2, including the current variants of concern (VOCs). With high bioavailability in the lungs and wide distribution in the body, the antibody was able to prevent SARS-CoV-2 infection in mice after intranasal administration.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Researchers examined the insurance claims and medical records of 681 patients with multiple sclerosis (MS) and found those who adhered to medication schedules had significantly better physical outcomes than patients who did not, although the total overall costs for their care were higher.
The effect of visit-to-visit blood pressure variability on mortality may be partly caused by changes in average values over time, say researchers.
› Verified 2 days ago
Nestor Manuel Quezada, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7305 N Military Trl, Riviera Beach, FL 33410 Phone: 561-422-7522 | |
Dr. Richard Harrison, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410 Phone: 561-422-7577 Fax: 561-422-7615 | |
Dr. Rudy Escarria, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410 Phone: 561-422-6957 Fax: 561-422-7615 | |
Dr. Antoinette Pignataro, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410 Phone: 561-422-7577 Fax: 561-422-7615 | |
Dr. David B Youel, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 7305 N Military Trl, Primary Care (110), Riviera Beach, FL 33410 Phone: 561-422-7577 Fax: 561-422-7615 | |
Dr. Lorna Sophia Barclay, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 7305 N Military Trl, Riviera Beach, FL 33410 Phone: 561-422-8262 |